Chardan’s 9th Annual Genetic Medicines Conference – October 21, 2025
Company management will participate in an RNA Editing panel at 1:00 p.m. ET and will conduct 1x1 investor meetings in conjunction with the conference.
H.C. Wainwright Liver Disease Virtual Conference – October 21-22, 2025
Presentation available on demand beginning October 21 at 7:00 am ET and virtual 1x1s on October 22
ProQR is participating in the H.C. Wainwright Genetic Medicines Virtual Conference – October 14-15, 2025
Presentation available on demand beginning October 14 at 7:00 am ET and virtual 1x1s on October 15
ProQR Therapeutics is a NASDAQ-listed biotechnology company headquartered in Leiden, the Netherlands, with an office in Cambridge, Massachusetts, USA. At ProQR, we are on a mission to edit RNA, treat disease, and change lives.
ProQR's Annual General Meeting (AGM) of Shareholders will take place on Tuesday, June 3, 2025 at 1530 CEST at the offices of Allen Overy Shearman Sterling LLP, in Amsterdam, the Netherlands.